Active, not recruitingPHASE1, PHASE2NCT05547464
Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- BioNTech SE
- Principal Investigator
- BioNTech Responsible PersonBioNTech SE
- Intervention
- BNT164a1(biological)
- Enrollment
- 497 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2027
Study locations (8)
- Centro de Investigação em Saúde de Manhiça (CISM) (recruiting participants for Part B only), Manhiça, Mozambique
- Centro de Investigação e Treino em Saúde da Polana Caniço (CISPOC) (recruiting participants for Part B only), Maputo, Mozambique
- CAPRISA eThekweni Clinical Research Site, Berea, South Africa
- South African Tuberculosis Vaccine Initiative SATVI, Cape Town, South Africa
- Centre for Lung Infection and Immunity UCT Lung Institute, Cape Town, South Africa
- Desmond Tutu Health Foundation - Masiphumele Research Office, Cape Town, South Africa
- Africa Health Research Institute (AHRI), Mtubatuba, South Africa
- The Aurum Institute Tembisa CRC Clinic 4, Tembisa, South Africa
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05547464 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet
- RECRUITINGPHASE3NCT06497465Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentJohns Hopkins University
- RECRUITINGNCT07178860Respiratory Health and Wellbeing Post Pulmonary TuberculosisLiverpool School of Tropical Medicine